SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Typen is Crynode's first MVP AI Agent designed to interact with both people and other AI agents. It leverages a combination of state-of-the-art AI models and advanced machine learning techniques to think, analyze, and navigate the Solana blockchain. Typen’s architecture is custom-built and advanced, setting it apart from starter frameworks like Eliza (ai16z), as shown by the depth of his responses. He’s built for head-to-head competition with shallow AIs like $goat (Terminal of Truths), aiming to provide real value rather than just entertainment. Typen represents the first pillar of Crynode's long-term vision: a future where high-quality AIs cooperate with humans to create sustainable, long-term wealth.

Typen

Typen is gaining attention, with community members highlighting its availability on Phantom Wallet as a key driver. The community is closely watching for a breakout, fueled by perceived strong support and rising volume. Overall sentiment suggests anticipation for potential upward movement.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petrobras is trending as the community discusses a potential retail squeeze and undervaluation, despite concerns about dividend cuts and political influence. Recent news highlights the company's increasing crude oil imports from Brazil by India and contract extensions for offshore growth. Community members are weighing the dividend yield against potential price suppression due to global oil market dynamics.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health is trending as the healthcare sector faces headwinds, with concerns around ACA subsidies and increasing insurance premiums driving community discussion. Despite recent price target adjustments and insider buying, the stock is experiencing volatility, influenced by broader industry trends and competitor performance. Some investors view the pullback as a long-term opportunity, citing undervaluation and potential for a rebound.

PagerDuty, Inc. engages in the provision of a digital operations management platform. Its products include incident management, automation, status pages, integrations, artificial intelligence for information technology operations (AIOps), customer service operations, and stakeholders’ communications. The firm's solutions include incident management transformation, operations center modernization, automation standardization, customer experience operations, digital operations resiliency, scaled service ownership, and remote-location operations. It also serves the financial services, healthcare, non-profit, public sector, and retail industries. The company was founded by Andrew Miklas, Baskar Puvanathasan, and Dan Alexandru Solomon in 2009 and is headquartered in San Francisco, CA.

Pagerduty Inc

PagerDuty is trending as investors discuss its potential as a retail squeeze play and possible buyout target, fueled by unusual options activity and speculation around Thoma Bravo making a bid. The community highlights the software technology growth, breaking above consolidation, and improving relative strength of the stock, while also considering platform usability compared to competitors. Heavy call buying suggests bullish sentiment, with some eyeing a potential run to $25 upon acquisition.

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.

GE HealthCare Technologies Inc

GE HealthCare is trending due to a new collaboration with Erasmus MC to advance precision imaging in cancer care using next-gen PET/CT technology and AI. Community discussion revolves around the potential impact of this partnership on early disease detection and GEHC's position in precision medicine, while some express concerns over revenue growth and recent downgrades.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to its low float and potential for a significant squeeze, with many traders closely watching for a breakout. Community members are noting the increasing number of watchers and the stock's strong performance in a weak market, anticipating a substantial move. Some traders suggest that a locked float, accumulation patterns, and a potential breakout above certain price points could trigger a rapid surge.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

ACON is trending due to community speculation about a potential short squeeze and upcoming events, with some eyeing a possible rally. However, concerns linger regarding the company's history of reverse stock splits and potential dilution, with many messages referencing a toxic relationship with Aclarion management. Despite the contrasting views, the stock's low float and after-hours momentum are contributing to heightened interest.

Diamondback Energy, Inc. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and exploitation of unconventional, onshore oil, and natural gas reserves. It operates through the Upstream and Midstream Services segments. The Upstream segment focuses on the Permian Basin operations in West Texas. The Midstream Services segment is involved in the Midland and Delaware Basins. The company was founded in December 2007 and is headquartered in Midland, TX.

Diamondback Energy Inc

Diamondback Energy is trending as traders discuss its potential as a retail squeeze stock, with significant options activity and bullish sentiment around future call options. Despite recent market volatility and fluctuations in oil prices, analysts highlight the company's strong fundamentals, capital efficiency, and commitment to returning value to investors through dividends and share buybacks. Some investors are also focusing on Diamondback's strategic positioning in the Permian Basin, particularly in relation to potential acquisitions and partnerships in the energy sector.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is currently trending as traders debate its next move amid market volatility and discussions around key price levels. Community members are weighing bullish and bearish scenarios, with some pointing to potential resistance and support levels. Broader market tensions, including trade dynamics and global uncertainties, appear to be influencing sentiment.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Protagonist Therapeutics is trending amid reports of acquisition talks with Johnson & Johnson, fueling speculation of a potential buyout. The community is actively discussing possible deal terms and the potential for a retail squeeze, while some express skepticism about the deal's certainty. PTGX is a clinical-stage biopharmaceutical company focused on discovering and developing innovative peptide-based therapeutics.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?

ALNY's portfolio of rare disease and cardiovascular drugs is boosting revenues and reducing reliance on Amvuttra.

Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

Alnylam (ALNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Alnylam's strong drug sales and advancing partnerships with Regeneron and Roche highlight key growth drivers in the quarters ahead.

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

Investors need to pay close attention to Alnylam Pharmaceuticals stock based on the movements in the options market lately.

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study.

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market.

Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?

Alnylam Pharmaceuticals (ALNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Are Medical Stocks Lagging  ADC Therapeutics (ADCT) This Year?

Here is how ADC Therapeutics SA (ADCT) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.

ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up

Alnylam stock jumps 15% after a surprise Q2 profit, driven by soaring Amvuttra sales and raised 2025 revenue guidance.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$460.46
Prev Close	$456.95
Open	$460.28
Dividend Yield	0.00%
50-Day Moving Average	$450.49
Beta	0.95
Avg. Volume	1.14M
PE Ratio	-186.65

52-Week High	$484.21
52-Week Low	$205.87
Market Capitalization	$60.36B
EPS (Annual)	-$2.18
Price to Book	240.67
Revenue Per Employee	$1.01M
Enterprise Value/EBITDA	N/A

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc